Kiran Musunuru of the Perelman School of Medicine spoke about the future of CRISPR-based treatments. “It's going to shift from a model where we're taking pills every day or injections every few weeks for long periods of time,” he said. “Gene editing therapies are going to transform that model into one where you have one-and-done therapies.”

October 25, 2021 ・ From The Scientist